The U.S. Food and Drug Administration (FDA) has announced FDA “PreCheck,” a new regulatory program intended to streamline the development and approval of domestic pharmaceutical manufacturing facilities. This initiative is part of the federal government’s broader effort to strengthen U.S. supply chain resilience and reduce reliance on overseas drug production. The program intends to offer
Latest Post
More Posts
FDA Issues Draft Guidance on Replacing Color Additives in Drug Products
Winston Kirton, Patrick Carpenter, Nikki Sanford, Laura Macherelli Join Food and Drug Law Journal Editorial Review Board
FDA Authorizes Marketing of Zyn Nicotine Pouches
The FDA’s New Definition of ‘Healthy’: A Step Forward, or a Step Too Far?
FDA Advances Proposal To Lower Nicotine in Cigarettes
Federal Court Blocks FDA’s Graphic Cigarette Warning Rule: The Limits of Regulatory Authority
Navigating FDA’s Guidance on Validation and Verification of Analytical Testing Methods for Tobacco Products
Cannabis Ballot Initiatives Ahead of the 2024 Election
Navigating the FDA’s SIUU Guidance: Key Insights for Pharma and MedTech
Subscribe: Subscribe via RSS